Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1986 Apr;23(4):687–690. doi: 10.1128/jcm.23.4.687-690.1986

Seroepidemiology of Klebsiella bacteremic isolates and implications for vaccine development.

S J Cryz Jr, P M Mortimer, V Mansfield, R Germanier
PMCID: PMC362817  PMID: 3517058

Abstract

The frequencies of capsular serotypes among 703 Klebsiella strains isolated from the blood of hospitalized patients were determined. More than 90% of the isolates were typeable, with 69 of the 77 known serotypes being identified. Serotypes 2, 21, and 55, representing 8.9, 7.8, and 4.8% of all the isolates, respectively, were observed at a frequency significantly higher (P less than 0.05) than that for other capsular serotypes. Approximately 43% of the serotypes appeared at a frequency of less than 0.5%. Differences were found when the seroepidemiology of North American and European isolates was compared. The current findings indicate that a capsular polysaccharide-based vaccine against Klebsiella organisms is feasible and should be multivalent, eliciting antibodies directed against the 25 serotypes which make up approximately 70% of all the bacteremic isolates.

Full text

PDF
687

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Austrian R., Douglas R. M., Schiffman G., Coetzee A. M., Koornhof H. J., Hayden-Smith S., Reid R. D. Prevention of pneumococcal pneumonia by vaccination. Trans Assoc Am Physicians. 1976;89:184–194. [PubMed] [Google Scholar]
  2. Bryan C. S., Reynolds K. L., Brenner E. R. Analysis of 1,186 episodes of gram-negative bacteremia in non-university hospitals: the effects of antimicrobial therapy. Rev Infect Dis. 1983 Jul-Aug;5(4):629–638. doi: 10.1093/clinids/5.4.629. [DOI] [PubMed] [Google Scholar]
  3. Cooper J. M., Rowley D. Resistance to Klebsiella pneumoniae and the importance of two bacterial antigens. Aust J Exp Biol Med Sci. 1982 Dec;60(6):629–641. doi: 10.1038/icb.1982.65. [DOI] [PubMed] [Google Scholar]
  4. Cross A. S., Gemski P., Sadoff J. C., Orskov F., Orskov I. The importance of the K1 capsule in invasive infections caused by Escherichia coli. J Infect Dis. 1984 Feb;149(2):184–193. doi: 10.1093/infdis/149.2.184. [DOI] [PubMed] [Google Scholar]
  5. Cryz S. J., Jr, Fürer E., Germanier R. Prevention of fatal experimental burn-wound sepsis due to Klebsiella pneumoniae KP1-O by immunization with homologous capsular polysaccharide. J Infect Dis. 1984 Dec;150(6):817–822. doi: 10.1093/infdis/150.6.817. [DOI] [PubMed] [Google Scholar]
  6. Cryz S. J., Jr, Fürer E., Germanier R. Protection against fatal Klebsiella pneumoniae burn wound sepsis by passive transfer of anticapsular polysaccharide. Infect Immun. 1984 Jul;45(1):139–142. doi: 10.1128/iai.45.1.139-142.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cryz S. J., Jr, Fürer E., Germanier R. Safety and immunogenicity of Klebsiella pneumoniae K1 capsular polysaccharide vaccine in humans. J Infect Dis. 1985 Apr;151(4):665–671. doi: 10.1093/infdis/151.4.665. [DOI] [PubMed] [Google Scholar]
  8. García de la Torre M., Romero-Vivas J., Martínez-Beltrán J., Guerrero A., Meseguer M., Bouza E. Klebsiella bacteremia: an analysis of 100 episodes. Rev Infect Dis. 1985 Mar-Apr;7(2):143–150. doi: 10.1093/clinids/7.2.143. [DOI] [PubMed] [Google Scholar]
  9. Graybill J. R., Marshall L. W., Charache P., Wallace C. K., Melvin V. B. Nosocomial pneumonia. A continuing major problem. Am Rev Respir Dis. 1973 Nov;108(5):1130–1140. doi: 10.1164/arrd.1973.108.5.1130. [DOI] [PubMed] [Google Scholar]
  10. Kiseleva B. S., Krasnogolovets V. N. Rol' Klebsiella pneumoniae v étiologii bakterial'nogo sepsisa. Zh Mikrobiol Epidemiol Immunobiol. 1983 Feb;(2):20–25. [PubMed] [Google Scholar]
  11. Kreger B. E., Craven D. E., Carling P. C., McCabe W. R. Gram-negative bacteremia. III. Reassessment of etiology, epidemiology and ecology in 612 patients. Am J Med. 1980 Mar;68(3):332–343. doi: 10.1016/0002-9343(80)90101-1. [DOI] [PubMed] [Google Scholar]
  12. MAIZTEGUI J. I., BIEGELEISEN J. Z., Jr, CHERRY W. B., KASS E. H. BACTEREMIA DUE TO GRAM-NEGATIVE RODS. A CLINICAL, BACTERIOLOGIC, SEROLOGIC AND IMMUNOFLUORESCENT STUDY. N Engl J Med. 1965 Feb 4;272:222–229. doi: 10.1056/NEJM196502042720502. [DOI] [PubMed] [Google Scholar]
  13. Martin W. J., Yu P. K., Washington J. A., 2nd Epidemiologic significance of Klebsiella pneumoniae. A 3-month study. Mayo Clin Proc. 1971 Dec;46(12):785–793. [PubMed] [Google Scholar]
  14. McCabe W. R., Kaijser B., Olling S., Uwaydah M., Hanson L. A. Escherichia coli in bacteremia: K and O antigens and serum sensitivity of strains from adults and neonates. J Infect Dis. 1978 Jul;138(1):33–41. doi: 10.1093/infdis/138.1.33. [DOI] [PubMed] [Google Scholar]
  15. Montgomerie J. Z. Epidemiology of Klebsiella and hospital-associated infections. Rev Infect Dis. 1979 Sep-Oct;1(5):736–753. doi: 10.1093/clinids/1.5.736. [DOI] [PubMed] [Google Scholar]
  16. Montgomerie J. Z., Ota J. K. Klebsiella bacteremia. Arch Intern Med. 1980 Apr;140(4):525–527. [PubMed] [Google Scholar]
  17. Murcia A., Rubin S. J. Reproducibility of an indirect immunofluorescent-antibody technique for capsular serotyping of Klebsiella pneumoniae. J Clin Microbiol. 1979 Feb;9(2):208–213. doi: 10.1128/jcm.9.2.208-213.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Palfreyman J. M. Klebsiella serotyping by counter-current immunoelectrophoresis. J Hyg (Lond) 1978 Oct;81(2):219–225. doi: 10.1017/s0022172400025043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Pier G. B., Thomas D. M. Lipopolysaccharide and high-molecular-weight polysaccharide serotypes of Pseudomonas aeruginosa. J Infect Dis. 1982 Feb;145(2):217–223. doi: 10.1093/infdis/145.2.217. [DOI] [PubMed] [Google Scholar]
  20. Rennie R. P., Duncan I. B. Combined biochemical and serological typing of clinical isolates of Klebsiella. Appl Microbiol. 1974 Oct;28(4):534–539. doi: 10.1128/am.28.4.534-539.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Riottot M. M., Fournier J. M., Jouin H. Direct evidence for the involvement of capsular polysaccharide in the immunoprotective activity of Klebsiella pneumoniae ribosomal preparations. Infect Immun. 1981 Jan;31(1):71–77. doi: 10.1128/iai.31.1.71-77.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Riser E., Noone P. Klebsiella capsular type versus site of isolation. J Clin Pathol. 1981 May;34(5):552–555. doi: 10.1136/jcp.34.5.552. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Robbins J. B., Austrian R., Lee C. J., Rastogi S. C., Schiffman G., Henrichsen J., Mäkelä P. H., Broome C. V., Facklam R. R., Tiesjema R. H. Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. J Infect Dis. 1983 Dec;148(6):1136–1159. doi: 10.1093/infdis/148.6.1136. [DOI] [PubMed] [Google Scholar]
  24. Selden R., Lee S., Wang W. L., Bennett J. V., Eickhoff T. C. Nosocomial klebsiella infections: intestinal colonization as a reservoir. Ann Intern Med. 1971 May;74(5):657–664. doi: 10.7326/0003-4819-74-5-657. [DOI] [PubMed] [Google Scholar]
  25. Ullmann U. The distribution of Klebsiella pneumoniae serotypes from different sources and their sensitivity to cephalosporins. Infection. 1983;11 (Suppl 1):S28–S31. doi: 10.1007/BF01641102. [DOI] [PubMed] [Google Scholar]
  26. Young L. S. Nosocomial infections in the immunocompromised adult. Am J Med. 1981 Feb;70(2):398–404. doi: 10.1016/0002-9343(81)90779-8. [DOI] [PubMed] [Google Scholar]
  27. ØRSKOV I. Serological investigations in the Klebsiella group. II. Occurrence of Klebsiella in sputa. Acta Pathol Microbiol Scand. 1955;36(5):454–460. doi: 10.1111/j.1699-0463.1955.tb04641.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES